On ECHEMI
Home > Drugs > Henan Jiushi Pharmaceutical Co., Ltd.

Henan Jiushi Pharmaceutical Co., Ltd.

  • Founded in:

    2002-06-24
  • Country:

    China China
  • Address:

    Southeast of Zhoubu Village, Huixian City
  • Tax NO.:

    91410700173249269M
  • Registered Funds:

    48 million yuan
  • Website:

  • Email:

Related Drugs
Inosine Tablets
Each tablet of this product contains 0.2 grams of the main ingredient inosine, and the auxiliary materials are starch, dextrin and sugar.
Name Description Content CAS NO. Registered Holders
Inosine

Participate in cell energy metabolism and protein synthesis in the body, increase the activity of related metabolic enzymes, improve liver function, and promote the recovery of damaged liver

More

Participate in cell energy metabolism and protein synthesis in the body, increase the activity of related metabolic enzymes, improve liver function, and promote the recovery of damaged liver

0.2g 58-63-9 8
Rifampicin Tablets
The main ingredient of this product is rifampicin, and its chemical name is 3-[[(4-methyl-1-piperazinyl)imino]methyl]-rifamycin.
Name Description Content CAS NO. Registered Holders
Rifampicin

Rifampicin is a semi-synthetic broad-spectrum antibacterial drug of the rifamycin class, which has antibacterial activity against a variety of pathogenic microorganisms. The drug has a significant bactericidal effect on Mycobacterium tuberculosis and some non-tuberculous mycobacteria (including Mycobacterium leprae, etc.) both inside and outside the host cells. It has a good antibacterial effect on aerobic Gram-positive bacteria, including enzyme-producing strains of Staphylococcus aureus and methicillin-resistant strains, Streptococcus pneumoniae, other Streptococcus, Enterococcus, Listeria, Bacillus anthracis, Clostridium perfringens, Corynebacterium diphtheriae, anaerobic cocci, etc. It also has a high degree of antibacterial activity against aerobic Gram-negative bacteria such as Neisseria meningitidis, Haemophilus influenzae, and Neisseria gonorrhoeae. Rifampicin also has a good effect on Legionella, and has an inhibitory effect on pathogens such as Chlamydia trachomatis, lymphogranuloma venereum, and psittacosis.

More

Rifampicin is a semi-synthetic broad-spectrum antibacterial drug of the rifamycin class, which has antibacterial activity against a variety of pathogenic microorganisms. The drug has a significant bactericidal effect on Mycobacterium tuberculosis and some non-tuberculous mycobacteria (including Mycobacterium leprae, etc.) both inside and outside the host cells. It has a good antibacterial effect on aerobic Gram-positive bacteria, including enzyme-producing strains of Staphylococcus aureus and methicillin-resistant strains, Streptococcus pneumoniae, other Streptococcus, Enterococcus, Listeria, Bacillus anthracis, Clostridium perfringens, Corynebacterium diphtheriae, anaerobic cocci, etc. It also has a high degree of antibacterial activity against aerobic Gram-negative bacteria such as Neisseria meningitidis, Haemophilus influenzae, and Neisseria gonorrhoeae. Rifampicin also has a good effect on Legionella, and has an inhibitory effect on pathogens such as Chlamydia trachomatis, lymphogranuloma venereum, and psittacosis.

13292-46-1 24
Acyclovir Tablets
The main ingredient of this product is acyclovir, and its chemical name is: 9-[(2-hydroxyethoxy)methyl]guanine
Name Description Content CAS NO. Registered Holders
Acyclovir

This product is an antiviral drug. It has an inhibitory effect on herpes simplex virus, varicella zoster virus, cytomegalovirus, etc. in vitro. After entering the cells infected by herpes virus, this product competes with deoxynucleoside for viral thymidine kinase or cell kinase, and the drug is phosphorylated into activated acyclovir triphosphate, and then inhibits viral replication in two ways: ① Interfering with viral DNA polymerase and inhibiting viral replication; ② Under the action of DNA polymerase, it binds to the growing DNA chain, causing the extension of the DNA chain to be interrupted. This product has a special affinity for viruses, but has low toxicity to mammalian host cells.

More

This product is an antiviral drug. It has an inhibitory effect on herpes simplex virus, varicella zoster virus, cytomegalovirus, etc. in vitro. After entering the cells infected by herpes virus, this product competes with deoxynucleoside for viral thymidine kinase or cell kinase, and the drug is phosphorylated into activated acyclovir triphosphate, and then inhibits viral replication in two ways: ① Interfering with viral DNA polymerase and inhibiting viral replication; ② Under the action of DNA polymerase, it binds to the growing DNA chain, causing the extension of the DNA chain to be interrupted. This product has a special affinity for viruses, but has low toxicity to mammalian host cells.

59277-89-3 50
Ranitidine Hydrochloride Tablets
The main ingredient of this product is: Ranitidine hydrochloride.
Name Description Content CAS NO. Registered Holders
Ranitidine Hydrochloride

It has the effect of competitively blocking the binding of histamine to H2 receptors and inhibiting the effect of gastric acid. Its molarity is 5 to 12 times that of cimetidine, making it a potent H2 receptor blocker.

More

It has the effect of competitively blocking the binding of histamine to H2 receptors and inhibiting the effect of gastric acid. Its molarity is 5 to 12 times that of cimetidine, making it a potent H2 receptor blocker.

66357-59-3 48
Oyster calcium carbonate tablets
The main component of this product is calcium compounds mainly composed of calcium carbonate and calcium hydroxide, which are obtained by calcining oyster shells at high temperature.
Name Description Content CAS NO. Registered Holders
Calcium compounds from oyster shells (mainly calcium carbonate and calcium hydroxide)

Participates in bone formation and reconstruction of bone tissue after fracture, as well as muscle contraction, nerve transmission, coagulation mechanism and reduces capillary permeability, etc.

More

Participates in bone formation and reconstruction of bone tissue after fracture, as well as muscle contraction, nerve transmission, coagulation mechanism and reduces capillary permeability, etc.

0
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.